Director, Enterprise Risk, Investigations & Remediation US Corporate Compliance Operations

BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions. Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered a portfolio of therapies since our founding in 1997. Our revolutionary treatments for conditions like achondroplasia (the most common form of dwarfism), PKU (phenylketonuria), CLN2, a form of Batten disease, and a number of forms of MPS (mucopolysaccharidosis) offer new possibilities for patients and families who previously had few, if any, available options. More recently, with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease, expanding our ability to reach more people living with rare genetic conditions. Our success comes from our unwavering commitment to excellence, our deep understanding of patient needs, our scientific expertise, and our world-class manufacturing capabilities. At the heart of BioMarin is a dedicated team of the brightest minds in the industry working together to deliver innovative therapies to patients and families around the world. About Corporate Groups It takes a village, and at BioMarin, our general and admin teams are the village behind our success. From the IT experts who manage our technology to the human resources professionals who hire the people who make it all possible, these teams support our organization and span all areas of operations.

Overview The Director, Enterprise Risk, Investigations & Remediation leads core elements of the US Corporate Compliance program focused on risk detection, internal investigations, remediation, and oversight of high-risk business activities, including advisory boards, speaker programs, and patient services.   This role is responsible for managing hotline matters and leading internal investigations, including ownership of the investigation case management system and end-to-end intake process, supporting enterprise and business unit risk assessments, translating monitoring and investigation findings into practical remediation plans, and developing risk reporting that supports leadership decision-making. The ideal candidate is a strong compliance operator and trusted cross-functional leader who can influence enterprise-wide compliance priorities, advise senior leadership on emerging risks, and ensure sustainable risk-based compliance frameworks that enable the business while protecting the organization.

Enterprise Risk Management & Risk Assessments Lead and coordinate US business unit risk assessment activities, including risk identification, prioritization, documentation, and follow-up planning. Lead risk budget inputs and cross-functional risk discussions to ensure resources are aligned to evolving compliance priorities. Identify emerging risk themes from investigations, monitoring, hotline activity, business initiatives, audits, and external enforcement trends. Present significant risk matters, investigation trends, remediation effectiveness, and emerging risk assessments to executive leadership and Compliance Committee audiences. Internal Investigations & Hotline Management Lead day-to-day hotline intake, triage, investigation planning, execution, documentation, and reporting for US Corporate Compliance matters. Lead investigations involving potential violations of healthcare compliance requirements, company policies, or expected business conduct. Partner with Legal, HR, business stakeholders, and relevant control functions to ensure appropriate investigation scope, factual development, stakeholder engagement, and escalation. Prepare clear investigation summaries, findings, recommendations, and leadership updates that are appropriately calibrated to the sensitivity and complexity of the matter. Identify repeat issues, root causes, and potential systemic concerns requiring broader remediation, training, control enhancement, or